BioSpace News Archive

Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital

Cipher Pharmaceuticals Inc. (TSX:CPH) today announced it has completed its previously announced acquisition of Cardiome Pharma Corp.

FamilyCord will maintain the long-term cryogenic storage of the stem cell units in its state-of-the-art biorepository.

Agreement represents the achievement of a major milestone for Anatara and its shareholders

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use by persons with diabetes, today announced that Chief Business Officer, Bashir Timol, will be presenting at the UBS Global Healthcare Conference, being held May 21-23, 2018 in New York.

Recursion Pharmaceuticals, today announced that it has hired Phil Carpino, Ph.D. and Mike Genin, Ph.D., to direct chemistry efforts.

Founding and leading Amneal Pharmaceuticals for 15 years, Mr. Patel and his brother Chirag transformed the company from a small, start-up generic manufacturer into the 5th largest generic pharmaceutical company in the U.S. Under the leadership of Chintu and Chirag Patel, Amneal grew to manufacture hundreds of generic pharmaceutical products in all dosage forms, including high barrier-to-entry forms.

As company scales, it adds two members to its board of directors

Personalis, Inc. announced that the State Intellectual Property Office of China has issued patent ZL 2013 8 00748247 for the ACE© Technology Platform.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the publication of data from the Phase III HALO study...